Advanced search
Publication Cover
International Journal of Nanomedicine Volume 13, 2018 - Issue
Submit an article Journal homepage
87
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Liposomal codelivery of an SN38 prodrug and a survivin siRNA for tumor therapy

Ye Bi1 School of Life Sciences, Jilin University, Changchun, Jilin, People’s Republic of China, [email protected]; [email protected]
,
Robert J Lee1 School of Life Sciences, Jilin University, Changchun, Jilin, People’s Republic of China, [email protected]; [email protected];2 Division of Pharmaceutics, College of Pharmacy, The Ohio State University, Columbus, OH, USA
,
Xinyu Wang1 School of Life Sciences, Jilin University, Changchun, Jilin, People’s Republic of China, [email protected]; [email protected]
,
Yating Sun1 School of Life Sciences, Jilin University, Changchun, Jilin, People’s Republic of China, [email protected]; [email protected]
,
Mengqiao Wang1 School of Life Sciences, Jilin University, Changchun, Jilin, People’s Republic of China, [email protected]; [email protected]
,
Lianlian Li1 School of Life Sciences, Jilin University, Changchun, Jilin, People’s Republic of China, [email protected]; [email protected]
,
Chenliang Li1 School of Life Sciences, Jilin University, Changchun, Jilin, People’s Republic of China, [email protected]; [email protected]
,
Jing Xie1 School of Life Sciences, Jilin University, Changchun, Jilin, People’s Republic of China, [email protected]; [email protected]Correspondence[email protected] [email protected]
&
Lesheng Teng1 School of Life Sciences, Jilin University, Changchun, Jilin, People’s Republic of China, [email protected]; [email protected]Correspondence[email protected] [email protected]
 show all
Pages 5811-5822 | Published online: 04 Oct 2018

References

  • GongoraCVezzio-VieNTuduriSNew Topoisomerase I mutations are associated with resistance to camptothecinMol Cancer2011106421619602
  • BalaVRaoSBoydBJPrestidgeCAProdrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38J Control Release20131721486123928356
  • DuYZhangWHeRDual 7-ethyl-10-hydroxycamptothecin conjugated phospholipid prodrug assembled liposomes with in vitro anticancer effectsBioorg Med Chem201725123247325828465086
  • AltieriDCSurvivin, cancer networks and pathway-directed drug discoveryNat Rev Cancer200881617018075512
  • LiFSurvivin study: what is the next wave?J Cell Physiol2003197182912942537
  • RyanBMO’DonovanNDuffyMJSurvivin: a new target for anticancer therapyCancer Treat Rev200935755356219559538
  • YanXYuQGuoLPositively Charged Combinatory Drug Delivery Systems against Multi-Drug-Resistant Breast Cancer: Beyond the Drug CombinationACS Appl Mater Interfaces2017986804681528185449
  • CuiZHuangLLiposome-polycation-DNA (LPD) particle as a carrier and adjuvant for protein-based vaccines: therapeutic effect against cervical cancerCancer Immunol Immunother200554121180119015846491
  • LiYLeeRJYuKDelivery of siRNA Using Lipid Nanoparticles Modified with Cell Penetrating PeptideACS Appl Mater Interfaces2016840266132662127617513
  • VivèsEBrodinPLebleuBA truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleusJ Biol Chem19972722516010160179188504
  • LuJLiuCWangPThe self-assembling camptothecin-tocopherol prodrug: An effective approach for formulating camptothecinBiomaterials20156217618726057133
  • HenneWADoorneweerdDDHilgenbrinkARKularatneSALowPSSynthesis and activity of a folate peptide camptothecin prodrugBioorg Med Chem Lett200616205350535516901694
  • ZhangWSongJZhangBLiuLWangKWangRDesign of acid-activated cell penetrating peptide for delivery of active molecules into cancer cellsBioconjug Chem20112271410141521663318
  • ChiuSJLiuSPerrottiDMarcucciGLeeRJEfficient delivery of a Bcl-2-specific antisense oligodeoxyribonucleotide (G3139) via transferrin receptor-targeted liposomesJ Control Release2006112219920716564596
  • YaoYSLiuJLXiJTotal synthesis of 7-ethyl-10-hydroxycamptothecin (SN38) and its application to the development of C18-functionalized camptothecin derivativesChemistry20111737104621046921850716
  • KumarRKimEJHanJHypoxia-directed and activated theranostic agent: Imaging and treatment of solid tumorBiomaterials201610411912827449948
  • WangHXieHWangJSelf-Assembling Prodrugs by Precise Programming of Molecular Structures that Contribute Distinct Stability, Pharmacokinetics, and Antitumor EfficacyAdv Funct Mater2015253149564965
  • ZhangYZhouCKwakKJEfficient siRNA delivery using a polyamidoamine dendrimer with a modified pentaerythritol corePharm Res20122961627163622274556
  • ThakurRSivakumarBSavvaMThermodynamic studies and loading of 7-ethyl-10-hydroxycamptothecin into mesoporous silica particles MCM-41 in strongly acidic solutionsJ Phys Chem B2010114175903591120380409
  • WangXZhouXHechtSMRole of the 20-hydroxyl group in camptothecin binding by the topoisomerase I-DNA binary complexBiochemistry199938144374438110194356
  • ZhangJAXuanTParmarMDevelopment and characterization of a novel liposome-based formulation of SN-38Int J Pharm20042701–29310714726126
  • PozziDColapicchioniVCaraccioloGEffect of polyethyleneglycol (PEG) chain length on the bio-nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cellsNanoscale2014652782279224463404
  • KorenETorchilinVPCell-penetrating peptides: breaking through to the other sideTrends Mol Med201218738539322682515

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.